Increasing Adoption in Breast Reconstruction Surgery of U.S. Acellular Dermal Matrices Market

Other
Sachin CMI's picture

Acellular dermal matrices (ADM) are medical devices derived from human or animal tissue that acts as scaffolds to support new tissue growth. They are used in various soft tissue reconstruction procedures such as breast reconstruction surgery, hernia repair, and wound repair to provide additional support and structure. ADM can be placed in a subcutaneous pocket to fill dead space and promote tissue ingrowth.

The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics

The U.S. Acellular Dermal Matrices Market is primarily driven by increasing adoption of ADM in breast reconstruction surgeries. According to the American Society of Plastic Surgeons (ASPS), approximately 129,000 breast reconstruction surgeries were performed in 2020 in the U.S. and the number is rising annually owing to rising breast cancer incidence rates in the country. ADM are commonly used in two-stage breast reconstruction surgeries to create a new breast mound and provide shape and symmetry. Another factor fueling the market growth is the growing popularity of ADM for hernia repair procedures. According to the HerniaSurge Group, over 800,000 hernia repair surgeries are performed annually in the U.S. With the rising hernia occurrence rates, the demand for ADM for hernia repair is also growing.

SWOT Analysis

Strength: Acellular dermal matrices are widely used for reconstructive surgeries involving the repair or replacement of soft tissue defects. They help enhance wound closure and promote new tissue formation at the wound site. These matrices are effective wound healing alternatives to patient's own skin grafts.

Weakness: Acellular dermal matrices undergo extensive processing involving the removal of cellular components which makes the matrix immunologically inert. However, this processing can compromise the mechanical and handling properties of the tissue. The acellular nature also prevents immediate vascularization at the wound site.

Opportunity: With rising cosmetic procedures and breast reconstruction surgeries, the demand for soft tissue matrices is surging in the U.S. Growing awareness about advanced tissue repair alternatives and their benefits over flaps and grafts will drive the market. The elderly population prone to injuries and surgical reconstructions present a lucrative customer segment.

Threats: Stringent regulations for tissue-based products can increase approval timelines and costs. Low reimbursement rates pressure margins. Patent expiries of top-selling matrices will enable entry of lower-cost generics. Raw material supply issues and price fluctuations pose challenges.

Key Takeaways

The U.S. Acellular Dermal Matrices Market Demand is expected to witness high growth over the forecast period supported by a growing geriatric population undergoing reconstructive procedures. The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 million in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030.

The regional analysis finds that the South holds the major market share currently due to higher volumes of reconstructive breast surgeries being performed in states like Texas and Florida. However, the West region is anticipated to record fastest gains owing to expanding surgical capabilities and a higher focus on aesthetic enhancement in states like California and Washington.

Key players operating in the U.S. acellular dermal matrices market are Biomet, Inc., Wright Medical Technology, Inc., Smith & Nephew Plc, and Stryker. Biomet dominates sales with its AlloDerm and GraftJacket matrices approved for a wide range of soft tissue reconstruction applications. Wright Medical focuses on sports medicine and conducts clinical trials to broaden indications of its Physiomesh. Stryker has a comprehensive portfolio addressing trauma, breast, and hernia repair needs.

Explore more information on this topic, Please visit -

https://www.pressreleasebulletin.com/u-s-acellular-dermal-matrices-market-size-and-tredns-analysis/ 

Explore more trending article on this topic -

https://diveintoinsights123.weebly.com/blog1/growing-demand-for-soft-tissue-reconstruction-for-us-acellular-dermal-matrices-market